Assembly Biosciences (ASMB) Short-term Investments (2015 - 2026)

Assembly Biosciences' Short-term Investments history runs 12 years deep, the most recent figure standing at $195.5 million for Q1 2026.

• On a quarterly basis, Short-term Investments rose 189.11% year-over-year to $195.5 million in Q1 2026; TTM through Mar 2026 was $195.5 million, a 189.11% increase from a year earlier, with the FY2025 full-year figure at $189.7 million, up 157.21% from the prior year.
• Short-term Investments climbed to $195.5 million in Q1 2026 per ASMB's latest filing, from $189.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $210.0 million in Q3 2025 and bottomed at $19.6 million in Q3 2023.
• The 5-year median for Short-term Investments is $71.8 million (2022), against an average of $86.7 million.
• Across the five-year window, Short-term Investments sank 63.77% in 2023 and jumped 240.09% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $39.2 million in 2022, then jumped by 181.71% to $110.4 million in 2023, then slumped by 33.21% to $73.7 million in 2024, then jumped by 157.21% to $189.7 million in 2025, then increased by 3.07% to $195.5 million in 2026.
• Per Business Quant, the three latest ASMB Short-term Investments figures stand at $195.5 million (Q1 2026), $189.7 million (Q4 2025), and $210.0 million (Q3 2025).